This inventor holds 1 USPTO granted patent and 1 published patent application, plus 2 CIPO patents and 2 EPO patents. Top assignee: Pfizer Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kristin Wiglesworth - Innovator in Pharmaceutical Research
Introduction
Kristin Wiglesworth is an accomplished inventor based in Germantown, MD (US). She is currently employed at Pfizer Corporation, where she contributes to innovative research in the pharmaceutical field. Although she does not hold any granted patents, her work is significant in the development of new treatments for various diseases.
Latest Patent Applications
Kristin's notable patent application is titled "Combinations Comprising Benzodioxol as GLP-1R Agonists for Use in the Treatment of NASH/NAFLD and Related Diseases." This invention provides a new combination that includes a GLP-1R agonist and an ACC inhibitor, DGAT2 inhibitor, KHK inhibitor, or FXR agonist. The application outlines new methods for treating diseases such as fatty liver, nonalcoholic fatty liver disease, and type 2 diabetes, among others.
Conclusion
Kristin Wiglesworth's contributions to pharmaceutical research highlight her dedication to advancing medical treatments, even in the absence of granted patents. Her innovative work at Pfizer Corporation is paving the way for future breakthroughs in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile